---
title: "Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293072080.md"
description: "AbbVie (NYSE:ABBV) has outperformed the market over the past decade with an annualized return of 14.83%, beating the market by 1.69%. A $1,000 investment made ten years ago would now be worth approximately $4,015, based on a current share price of $256.94. The company currently holds a market capitalization of $454.46 billion."
datetime: "2026-07-17T20:15:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293072080.md)
  - [en](https://longbridge.com/en/news/293072080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293072080.md)
---

# Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 1.69% on an annualized basis producing an average annual return of 14.83%. Currently, AbbVie has a market capitalization of $454.46 billion.

**Buying $1000 In ABBV:** If an investor had bought $1000 of ABBV stock 10 years ago, it would be worth **$4,014.98** today based on a price of $256.94 for ABBV at the time of writing.

### AbbVie’s Performance Over Last 10 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/07/17/cdc13d88e7083ac1b9c7b6bfb08de1ca.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md)
- [AbbVie Inc. $ABBV Shares Bought by Opal Capital LLC](https://longbridge.com/en/news/294190325.md)
- [The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo](https://longbridge.com/en/news/294200563.md)
- [Bank of Nova Scotia Cuts Stock Position in AbbVie Inc. $ABBV](https://longbridge.com/en/news/293717083.md)
- [AbbVie Target of Unusually High Options Trading (NYSE:ABBV)](https://longbridge.com/en/news/292681029.md)